Literature DB >> 21368344

Age-associated bone loss and intraskeletal variability in the Imperial Romans.

Helen Cho1, Sam Darrel Stout.   

Abstract

An Imperial Roman sample from the Isola Sacra necropolis (100-300 A.D.) offered an opportunity to histologically examine bone loss and intraskeletal variability in an urban archaeological population. Rib and femur samples were analyzed for static indices of bone remodeling and measures of bone mass. The Imperial Romans experienced normal age-associated bone loss via increased intracortical porosity and endosteal expansion, with females exhibiting greater bone loss and bone turnover rates than in males. Life events such as menopause and lactation coupled with cultural attitudes and practices regarding gender and food may have led to increased bone loss in females. Remodeling dynamics differ between the rib and femur and the higher remodeling rates in the rib may be attributed to different effective age of the adult compacta or loading environment. This study demonstrates that combining multiple methodologies to examine bone loss is necessary to shed light on the biocultural factors that influence bone mass and bone loss.

Entities:  

Mesh:

Year:  2011        PMID: 21368344     DOI: 10.4436/jass.89007

Source DB:  PubMed          Journal:  J Anthropol Sci        ISSN: 1827-4765


  3 in total

1.  Intra-skeletal vascular density in a bipedal hopping macropod with implications for analyses of rib histology.

Authors:  Tahlia J Stewart; Julien Louys; Justyna J Miszkiewicz
Journal:  Anat Sci Int       Date:  2021-01-22       Impact factor: 1.741

2.  Characteristics of Chinese Costal Cartilage and Costa Calcification Using Dual-Energy Computed Tomography Imaging.

Authors:  Shanyong Zhang; Jinze Zhen; Huiping Li; Shoufu Sun; Huawei Wu; Pei Shen; Zengai Chen; Chi Yang
Journal:  Sci Rep       Date:  2017-06-07       Impact factor: 4.379

3.  Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility.

Authors:  Calen P Ryan; Bernard J Crespi
Journal:  Evol Appl       Date:  2012-06-11       Impact factor: 5.183

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.